大葉大學圖書館 |

Access to medicine versus test data exclusivity[electronic resource] :safeguarding flexibilities under international law /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	362.10973
書名/作者:	Access to medicine versus test data exclusivity : safeguarding flexibilities under international law // by Owais H. Shaikh.
作者:	Shaikh, Owais H.
出版者:	Berlin, Heidelberg : : Springer Berlin Heidelberg :, 2016.
面頁冊數:	xvi, 256 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Medical policy.
標題:	Law.
標題:	International IT and Media Law, Intellectual Property Law.
標題:	Private International Law, International & Foreign Law, Comparative Law.
標題:	International Economic Law, Trade Law.
標題:	Law and Economics.
ISBN:	9783662496558
ISBN:	9783662496541
內容註:	Introduction -- Test Data Exclusivity: Raison d'etre -- Test Data Exclusivity and Art 39(3) TRIPS -- Test Data Exclusivity in the US and the EU -- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements -- Index of Data Exclusivity and Access (IDEAS) - National Laws -- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals -- Conclusions and Recommendations.
摘要、提要註:	This book explores the concept of test data exclusivity protection for pharmaceuticals. Focusing on Art 39(3) of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and relevant provisions in selected free trade agreements (FTA) and national laws, it combines normative, historical, comparative and economic analysis of test data exclusivity protection. At the heart of this book is the novel and original Index of Data Exclusivity and Access (IDEAS), which analyzes the effectiveness of test data exclusivity provisions in FTAs and national laws both on the strength of exclusivity as well as on access to medicine. IDEAS provides a framework for the assessment of current test data exclusivity protection standards on the basis of their proximity to Article 39(3) of the TRIPS Agreement, the scope of exclusivity and the flexibilities in FTAs, and subsequently in national laws. This book aims to broaden national and international policy makers' grasp of the various nuances of test data exclusivity protection. Furthermore, it provides practical recommendations with regard to designing an appropriate legal system with a strong focus on promoting access to medicine for all.
電子資源:	http://dx.doi.org/10.1007/978-3-662-49655-8

Access to medicine versus test data exclusivity[electronic resource] :safeguarding flexibilities under international law /
Shaikh, Owais H.

Access to medicine versus test data exclusivitysafeguarding flexibilities under international law /[electronic resource] :by Owais H. Shaikh. - Berlin, Heidelberg :Springer Berlin Heidelberg :2016. - xvi, 256 p. :ill., digital ;24 cm. - Munich studies on innovation and competition,42199-7462 ;. - Munich studies on innovation and competition ;v.1..

Introduction -- Test Data Exclusivity: Raison d'etre -- Test Data Exclusivity and Art 39(3) TRIPS -- Test Data Exclusivity in the US and the EU -- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements -- Index of Data Exclusivity and Access (IDEAS) - National Laws -- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals -- Conclusions and Recommendations.

This book explores the concept of test data exclusivity protection for pharmaceuticals. Focusing on Art 39(3) of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and relevant provisions in selected free trade agreements (FTA) and national laws, it combines normative, historical, comparative and economic analysis of test data exclusivity protection. At the heart of this book is the novel and original Index of Data Exclusivity and Access (IDEAS), which analyzes the effectiveness of test data exclusivity provisions in FTAs and national laws both on the strength of exclusivity as well as on access to medicine. IDEAS provides a framework for the assessment of current test data exclusivity protection standards on the basis of their proximity to Article 39(3) of the TRIPS Agreement, the scope of exclusivity and the flexibilities in FTAs, and subsequently in national laws. This book aims to broaden national and international policy makers' grasp of the various nuances of test data exclusivity protection. Furthermore, it provides practical recommendations with regard to designing an appropriate legal system with a strong focus on promoting access to medicine for all.

ISBN: 9783662496558

Standard No.: 10.1007/978-3-662-49655-8doiSubjects--Topical Terms:

379454
Medical policy.

LC Class. No.: RA395.A3 / S53 2016

Dewey Class. No.: 362.10973

Access to medicine versus test data exclusivity[electronic resource] :safeguarding flexibilities under international law /
LDR:02690nmm a2200325 a 4500 001 462288
003 DE-He213
005 20160725195219.0
006 m d
007 cr nn 008maaau
008 170223s2016 gw s 0 eng d
020 $a 9783662496558 $q (electronic bk.)
020 $a 9783662496541 $q (paper)
024 7 $a 10.1007/978-3-662-49655-8 $2 doi
035 $a 978-3-662-49655-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RA395.A3 $b S53 2016
072 7 $a LN $2 bicssc
072 7 $a LAW051000 $2 bisacsh
082 0 4 $a 362.10973 $2 23
090 $a RA395.A3 $b S526 2016
100 1 $a Shaikh, Owais H. $3 666698
245 1 0 $a Access to medicine versus test data exclusivity $h [electronic resource] : $b safeguarding flexibilities under international law / $c by Owais H. Shaikh.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2016.
300 $a xvi, 256 p. : $b ill., digital ; $c 24 cm.
490 1 $a Munich studies on innovation and competition, $x 2199-7462 ; $v 4
505 0 $a Introduction -- Test Data Exclusivity: Raison d'etre -- Test Data Exclusivity and Art 39(3) TRIPS -- Test Data Exclusivity in the US and the EU -- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements -- Index of Data Exclusivity and Access (IDEAS) - National Laws -- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals -- Conclusions and Recommendations.
520 $a This book explores the concept of test data exclusivity protection for pharmaceuticals. Focusing on Art 39(3) of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and relevant provisions in selected free trade agreements (FTA) and national laws, it combines normative, historical, comparative and economic analysis of test data exclusivity protection. At the heart of this book is the novel and original Index of Data Exclusivity and Access (IDEAS), which analyzes the effectiveness of test data exclusivity provisions in FTAs and national laws both on the strength of exclusivity as well as on access to medicine. IDEAS provides a framework for the assessment of current test data exclusivity protection standards on the basis of their proximity to Article 39(3) of the TRIPS Agreement, the scope of exclusivity and the flexibilities in FTAs, and subsequently in national laws. This book aims to broaden national and international policy makers' grasp of the various nuances of test data exclusivity protection. Furthermore, it provides practical recommendations with regard to designing an appropriate legal system with a strong focus on promoting access to medicine for all.
650 0 $a Medical policy. $3 379454
650 1 4 $a Law. $3 464046
650 2 4 $a International IT and Media Law, Intellectual Property Law. $3 468380
650 2 4 $a Private International Law, International & Foreign Law, Comparative Law. $3 464780
650 2 4 $a International Economic Law, Trade Law. $3 465634
650 2 4 $a Law and Economics. $3 465280
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Munich studies on innovation and competition ; $v v.1. $3 603445
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-49655-8
950 $a Law and Criminology (Springer-41177)